Active substance
Results for the substance sapropterin
2 results
About this active substance
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), an essential cofactor for enzymes involved in the metabolism of aromatic amino acids such as phenylalanine, tyrosine, and tryptophan. It is used in the treatment of hyperphenylalaninemia (HPA) caused by phenylketonuria (PKU) or other BH4 metabolism deficiencies.
Sapropterin is administered orally, usually once daily, and is indicated for patients who respond to BH4 therapy, as determined by sensitivity tests. It helps reduce blood phenylalanine levels, preventing toxic accumulation and associated neurological complications.
Common side effects include headache, nausea, diarrhea, and cold-like symptoms. In rare cases, allergic reactions or worsening of neurological symptoms may occur. Regular monitoring of phenylalanine levels is essential for dose adjustment and treatment optimization.
Sapropterin is an important therapeutic option for patients with PKU, helping to improve quality of life and prevent long-term complications.
Sapropterin is administered orally, usually once daily, and is indicated for patients who respond to BH4 therapy, as determined by sensitivity tests. It helps reduce blood phenylalanine levels, preventing toxic accumulation and associated neurological complications.
Common side effects include headache, nausea, diarrhea, and cold-like symptoms. In rare cases, allergic reactions or worsening of neurological symptoms may occur. Regular monitoring of phenylalanine levels is essential for dose adjustment and treatment optimization.
Sapropterin is an important therapeutic option for patients with PKU, helping to improve quality of life and prevent long-term complications.